Announcement by the Bicycle therapeutics that the presentation at the ESMO 2019 Annual Congress of updated data from the Phase I / IIa trial evaluating BT1718 in patients with advanced solid tumors

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology firm pioneering a new therapeutic class based on its proprietary bicyclic peptide (Bicycles ®) product platform, announced today the introduction of updated information from a Phase I / IIa trial in cooperation with…

The main highlight of the Middle East Treasurer Summit: The latest technological developments.

The organizers announced further characteristics of the program a few days before the 11th annual summit of treasurers for the Middle East in Madinat Jumeirah in Dubai, from 1-2 October. Organized by the Association of Corporate Treasurers (ACT) and open…